Asarina Pharma

About Us

Asarina Pharma Asarina Pharma is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders. Our product pipeline is built on over 40 years of research, and with our new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) we aim to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions from Tourette syndrome to OCD..

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

First patient dosed in landmark Menstrual Migraine study

Thu, Dec 05, 2019 12:47 CET

Asarina Pharma AB (publ) (ASAP: FN Stockholm) has administered the first dose in its Phase IIa trial of a new, preventative treatment for menstrual migraine. Sepranolone is the first woman-only migraine treatment, specifically targeting menstrual migraine.Globally, three times more women than men suffer from migraine. Approximately 50 million of those also suffer from menstrual migraine, a more severe form highly resistant to standard treatments, including recently developed CGRP antibodies. Sepranolone is the first compound to target this highly frequent form of female migraine. If

There are no items matching the current filter

There are no more items matching the current filter

Back to top

Share

About Us

First patient dosed in landmark Menstrual Migraine study

Subscribe